Antibacterial potential of selected 4-phenyl hydroxycoumarins: integrated in vitro and molecular docking studies
暂无分享,去创建一个
D. Stojanovic | A. Veselinović | J. Veselinovic | T. Mihajilov-Krstev | S. Pešić | J. Matejić | G. Nikolić | Jelena S. Matejić
[1] I. Damnjanovic,et al. Monte Carlo Method Based QSAR Modeling of Coumarin Derivates as Potent HIV‐1 Integrase Inhibitors and Molecular Docking Studies of Selected 4‐phenyl Hydroxycoumarins , 2014 .
[2] G. Nikolic,et al. Antioxidant properties of selected 4-phenyl hydroxycoumarins: Integrated in vitro and computational studies. , 2014, Chemico-biological interactions.
[3] Wei Zhou,et al. 4-Hydroxy-3-(naphthalen-1-ylmethyl)thiophen-2(5H)-one as inhibitors of tyrosyl-tRNA synthase: Synthesis, molecular docking and antibacterial evaluation , 2014 .
[4] T. Tomašič,et al. Prospects for developing new antibacterials targeting bacterial type IIA topoisomerases. , 2013, Current topics in medicinal chemistry.
[5] C. Kaushik,et al. Synthesis and biological evaluation of amino acid-linked 1,2,3-bistriazole conjugates as potential antimicrobial agents , 2013, Medicinal Chemistry Research.
[6] S. Joshi,et al. Synthesis, biological evaluation and docking studies of 4-aryloxymethyl coumarins derived from substructures and degradation products of vancomycin. , 2013, European journal of medicinal chemistry.
[7] Cheng‐He Zhou,et al. Current developments of coumarin compounds in medicinal chemistry. , 2013, Current pharmaceutical design.
[8] Cheng‐He Zhou,et al. Synthesis and biological activities of thio-triazole derivatives as novel potential antibacterial and antifungal agents , 2012, Science China Chemistry.
[9] Cheng‐He Zhou,et al. 7-(6-Bromohexyloxy)-4-methyl-2H-chromen-2-one , 2012, Acta crystallographica. Section E, Structure reports online.
[10] Y. Asiri,et al. Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study. , 2011, European journal of medicinal chemistry.
[11] Roman A. Laskowski,et al. LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery , 2011, J. Chem. Inf. Model..
[12] X. Liang,et al. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones. , 2011, European journal of medicinal chemistry.
[13] Steven J. M. Jones,et al. A Computational Approach to Finding Novel Targets for Existing Drugs , 2011, PLoS Comput. Biol..
[14] F. Hsu,et al. Synthesis and Evaluation of Antibacterial Activities of 5,7‐Dihydroxycoumarin Derivatives , 2011, Archiv der Pharmazie.
[15] M. Saleem,et al. Antimicrobial Natural Products: An Update on Future Antibiotic Drug Candidates , 2010 .
[16] N. Farag,et al. Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photoreagent towards DNA and as antimicrobial agents. , 2010, European journal of medicinal chemistry.
[17] Abdul Jabbar,et al. Antimicrobial natural products: an update on future antibiotic drug candidates. , 2010, Natural product reports.
[18] Mark B Gerstein,et al. Computational analysis of membrane proteins: the largest class of drug targets. , 2009, Drug discovery today.
[19] Ruian Xu,et al. The structure and pharmacological functions of coumarins and their derivatives. , 2009, Current medicinal chemistry.
[20] Henry F. Chambers,et al. Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.
[21] Christopher T. Walsh,et al. Antibiotics for Emerging Pathogens , 2009, Science.
[22] T. Smyth,et al. A study of the antimicrobial activity of selected naturally occurring and synthetic coumarins. , 2009, International journal of antimicrobial agents.
[23] R. Kroemer. Structure-based drug design: docking and scoring. , 2007, Current protein & peptide science.
[24] F. Ausubel,et al. Prospects for plant-derived antibacterials , 2006, Nature Biotechnology.
[25] René Thomsen,et al. MolDock: a new technique for high-accuracy molecular docking. , 2006, Journal of medicinal chemistry.
[26] F. Monache,et al. Antibacterial Activity of Coumarins , 2005, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[27] E Uriarte,et al. Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. , 2005, Current medicinal chemistry.
[28] A. Sartoratto,et al. Composition and antimicrobial activity of essential oils from aromatic plants used in Brazil , 2004 .
[29] S. Levy,et al. Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.
[30] V. Khilya,et al. Neoflavones. 1. Natural Distribution and Spectral and Biological Properties , 2004, Chemistry of Natural Compounds.
[31] P. Geerlings,et al. Conceptual density functional theory. , 2003, Chemical reviews.
[32] Xiayang Qiu,et al. Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors , 2001, Protein science : a publication of the Protein Society.
[33] O. Kayser,et al. Antibacterial Activity of Simple Coumarins: Structural Requirements for Biological Activity , 1999, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[34] A. Becke. Density-functional thermochemistry. , 1996 .
[35] A. Becke. Density-functional thermochemistry. III. The role of exact exchange , 1993 .
[36] H. Neu,et al. The Crisis in Antibiotic Resistance , 1992, Science.
[37] T. Mabry,et al. Two new neoflavonoids and C-glycosylflavones from Passiflora serratodigitata , 1982 .
[38] H. Falk,et al. Progress in the Chemistry of Organic Natural Products , 2017 .
[39] M. Gellert,et al. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[40] G. Gribble,et al. Progress in the Chemistry of Organic Natural Products , 2011 .